Current and historical daily PE Ratio for Sopharma AD-Sofia (
FRA:3JR
) from 2010 to May 16 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sopharma AD-Sofia stock (FRA:3JR) PE ratio as of May 16 2024 is 8.67.
More Details
Sopharma AD-Sofia (FRA:3JR) PE Ratio (TTM) Chart
Sopharma AD-Sofia (FRA:3JR) PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Total 537
- 1
- 2
- 3
- 4
- 5
- 6
| Sopharma AD-Sofia PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-16 | At Loss | 2023-01-11 | 6.8 |
| 2023-03-16 | 6.8 | 2023-01-10 | 6.8 |
| 2023-03-15 | 6.8 | 2023-01-09 | 6.8 |
| 2023-03-14 | 6.8 | 2023-01-06 | 6.8 |
| 2023-03-13 | 6.8 | 2023-01-05 | 6.8 |
| 2023-03-10 | 6.8 | 2023-01-04 | 6.8 |
| 2023-03-09 | 6.8 | 2023-01-03 | 6.8 |
| 2023-03-08 | 6.8 | 2023-01-02 | 6.8 |
| 2023-03-07 | 6.8 | 2022-12-30 | 6.8 |
| 2023-03-06 | 6.8 | 2022-12-29 | 6.8 |
| 2023-03-03 | 6.8 | 2022-12-28 | 6.8 |
| 2023-03-02 | 6.8 | 2022-12-27 | 4.5 |
| 2023-03-01 | 6.8 | 2022-12-26 | 4.5 |
| 2023-02-27 | 6.8 | 2022-12-23 | 4.5 |
| 2023-02-24 | 6.8 | 2022-12-22 | 4.5 |
| 2023-02-23 | 6.8 | 2022-12-21 | 4.5 |
| 2023-02-22 | 6.8 | 2022-12-20 | 4.5 |
| 2023-02-21 | 6.8 | 2022-12-19 | 4.5 |
| 2023-02-20 | 6.8 | 2022-12-16 | 4.5 |
| 2023-02-17 | 6.8 | 2022-12-15 | 4.5 |
| 2023-02-16 | 6.8 | 2022-12-14 | 4.5 |
| 2023-02-15 | 6.8 | 2022-12-13 | 4.5 |
| 2023-02-14 | 6.8 | 2022-12-12 | 4.5 |
| 2023-02-13 | 6.8 | 2022-12-09 | 4.5 |
| 2023-02-10 | 6.8 | 2022-12-08 | 4.5 |
| 2023-02-09 | 6.8 | 2022-12-07 | 4.5 |
| 2023-02-08 | 6.8 | 2022-12-06 | 4.5 |
| 2023-02-07 | 6.8 | 2022-12-05 | 4.5 |
| 2023-02-06 | 6.8 | 2022-12-02 | 4.5 |
| 2023-02-03 | 6.8 | 2022-12-01 | 4.5 |
| 2023-02-02 | 6.8 | 2022-11-30 | 4.5 |
| 2023-02-01 | 6.8 | 2022-11-29 | 4.5 |
| 2023-01-30 | 6.8 | 2022-11-28 | 4.5 |
| 2023-01-27 | 6.8 | 2022-11-25 | 4.5 |
| 2023-01-26 | 6.8 | 2022-11-24 | 4.5 |
| 2023-01-25 | 6.8 | 2022-11-23 | 4.5 |
| 2023-01-24 | 6.8 | 2022-11-22 | 4.5 |
| 2023-01-23 | 6.8 | 2022-11-21 | 4.5 |
| 2023-01-20 | 6.8 | 2022-11-18 | 4.5 |
| 2023-01-19 | 6.8 | 2022-11-17 | 4.5 |
| 2023-01-18 | 6.8 | 2022-11-16 | 4.5 |
| 2023-01-17 | 6.8 | 2022-11-15 | 4.5 |
| 2023-01-16 | 6.8 | 2022-11-14 | 4.5 |
| 2023-01-13 | 6.8 | 2022-11-11 | 4.5 |
| 2023-01-12 | 6.8 | 2022-11-10 | 4.5 |
Sopharma AD-Sofia (FRA:3JR) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Sopharma AD-Sofia
NAICS : 325412
ISIN : BG11SOSOBT18
Compare
Compare
Traded in other countries / regions
SFA.BulgariaSPH.Poland3JR.Germany IPO Date
2010-03-22Description
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers